Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 469.00
-18.00 (-3.70%)
May 12, 2026, 3:30 PM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 16.43 billion as of May 12, 2026. Its market cap has increased by 48.09% in one year.
Market Cap
16.43B
Enterprise Value
14.53B
Revenue
968.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
469.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 16.43B, a decrease of -30.76%. That is a compound annual growth rate of -7.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 16.43B | 137.82% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 23.88B |
| AnGes | 21.01B |
| RaQualia Pharma | 20.69B |
| StemRIM | 18.80B |
| Renascience | 17.33B |
| ReproCELL | 16.54B |
| CanBas | 13.05B |
| Immuno-Biological Laboratories | 13.00B |